About
Immunotherapy
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyTaiwan
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
108
By Phase
PHASE2: 1PHASE1: 2
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06745583Lead Sponsor
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
PHASE2Recruiting
15 participants
Started: Dec 16, 2024 · Completed: Jun 30, 2026
NCT04994912Lead Sponsor
First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers
PHASE1Completed
35 participants
Started: Oct 1, 2021 · Completed: Feb 18, 2025
NCT04238364Lead Sponsor
A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers
PHASE1Completed
58 participants
Started: Dec 27, 2019 · Completed: Jan 10, 2022
Locations (1)
Headquarters
Taipei, Taiwan
Map
Loading map...